Literature DB >> 17317856

Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.

Zhuyan Guo1, Marei Dose, Damian Kovalovsky, Rui Chang, Jennifer O'Neil, A Thomas Look, Harald von Boehmer, Khashayarsha Khazaie, Fotini Gounari.   

Abstract

Activation of beta-catenin has been causatively linked to the etiology of colon cancer. Conditional stabilization of this molecule in pro-T cells promotes thymocyte development without the requirement for pre-TCR signaling. We show here that activated beta-catenin stalls the developmental transition from the double-positive (DP) to the single-positive (SP) thymocyte stage and predisposes DP thymocytes to transformation. beta-Catenin-induced thymic lymphomas have a leukemic arrest at the early DP stage. Lymphomagenesis requires Rag activity, which peaks at this developmental stage, as well as additional secondary genetic events. A consistent secondary event is the transcriptional up-regulation of c-Myc, whose activity is required for transformation because its conditional ablation abrogates lymphomagenesis. In contrast, the expression of Notch receptors as well as targets is reduced in DP thymocytes with stabilized beta-catenin and remains low in the lymphomas, indicating that Notch activation is not required or selected for in beta-catenin-induced lymphomas. Thus, beta-catenin activation may provide a mechanism for the induction of T-cell-acute lymphoblastic leukemia (T-ALL) that does not depend on Notch activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317856      PMCID: PMC1890819          DOI: 10.1182/blood-2006-11-059071

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

Review 1.  Notch signaling in T cell development.

Authors:  M L Deftos; M J Bevan
Journal:  Curr Opin Immunol       Date:  2000-04       Impact factor: 7.486

2.  Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.

Authors:  S Kishida; H Yamamoto; S Ikeda; M Kishida; I Sakamoto; S Koyama; A Kikuchi
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

3.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.

Authors:  J Behrens; B A Jerchow; M Würtele; J Grimm; C Asbrand; R Wirtz; M Kühl; D Wedlich; W Birchmeier
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

4.  Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.

Authors:  J Jonkers; H C Korswagen; D Acton; M Breuer; A Berns
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

5.  Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.

Authors:  R M Okamura; M Sigvardsson; J Galceran; S Verbeek; H Clevers; R Grosschedl
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

6.  Interaction of dishevelled and Xenopus axin-related protein is required for wnt signal transduction.

Authors:  K Itoh; A Antipova; M J Ratcliffe; S Sokol
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.

Authors:  N Harada; Y Tamai; T Ishikawa; B Sauer; K Takaku; M Oshima; M M Taketo
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

8.  V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.

Authors:  M Nacht; T Jacks
Journal:  Cell Growth Differ       Date:  1998-02

9.  Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.

Authors:  D Cook; M J Fry; K Hughes; R Sumathipala; J R Woodgett; T C Dale
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

10.  beta-catenin is a target for the ubiquitin-proteasome pathway.

Authors:  H Aberle; A Bauer; J Stappert; A Kispert; R Kemler
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

View more
  61 in total

1.  The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation.

Authors:  Wook-Jin Chae; Allison K Ehrlich; Pamela Y Chan; Alexandra M Teixeira; Octavian Henegariu; Liming Hao; Jae Hun Shin; Jong-Hyun Park; Wai Ho Tang; Sang-Taek Kim; Stephen E Maher; Karen Goldsmith-Pestana; Peiying Shan; John Hwa; Patty J Lee; Diane S Krause; Carla V Rothlin; Diane McMahon-Pratt; Alfred L M Bothwell
Journal:  Immunity       Date:  2016-02-09       Impact factor: 31.745

Review 2.  β-catenin/TCF-1 pathway in T cell development and differentiation.

Authors:  Jian Ma; Ruiqing Wang; Xianfeng Fang; Zuoming Sun
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-27       Impact factor: 4.147

3.  Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling.

Authors:  Vincenzo Giambra; Catherine E Jenkins; Sonya H Lam; Catherine Hoofd; Miriam Belmonte; Xuehai Wang; Sam Gusscott; Deanne Gracias; Andrew P Weng
Journal:  Blood       Date:  2015-05-01       Impact factor: 22.113

4.  Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Takaomi Sanda; Wenxue Ma; Jianhua Zhang; Ruta Grebliunaite; Suzanne Dahlberg; Donna Neuberg; Alexei Protopopov; Stuart S Winter; Richard S Larson; Michael J Borowitz; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Catriona Jamieson; Stephen E Sallan; A Thomas Look
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

Review 5.  Wnt signaling in normal and malignant hematopoiesis.

Authors:  William Lento; Kendra Congdon; Carlijn Voermans; Marcie Kritzik; Tannishtha Reya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

6.  Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Xiaoyu Li; Alejandro Gutierrez; Yebin Ahn; Donna S Neuberg; Jennifer O'Neil; Peter R Strack; Christopher G Winter; Stuart S Winter; Richard S Larson; Harald von Boehmer; A Thomas Look
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

7.  Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.

Authors:  Hind Medyouf; Xiuhua Gao; Florence Armstrong; Samuel Gusscott; Qing Liu; Amanda Larson Gedman; Larry H Matherly; Kirk R Schultz; Francoise Pflumio; Mingjian James You; Andrew P Weng
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

Review 8.  TCF1 and beta-catenin regulate T cell development and function.

Authors:  Qing Yu; Archna Sharma; Jyoti Misra Sen
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

9.  Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia.

Authors:  Smita Dandekar; Eleny Romanos-Sirakis; Faye Pais; Teena Bhatla; Courtney Jones; Wallace Bourgeois; Stephen P Hunger; Elizabeth A Raetz; Michelle L Hermiston; Ramanuj Dasgupta; Debra J Morrison; William L Carroll
Journal:  Br J Haematol       Date:  2014-07-04       Impact factor: 6.998

10.  A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice.

Authors:  Malay Haldar; Matthew L Hedberg; Matthew F Hockin; Mario R Capecchi
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.